Silo Pharma raises $2M in registered direct offering with warrants

Silo Pharma, Inc.

Sold 917,432 shares at $2.18/share and issued warrants for 917,432 shares at $2.06 exercise price.
Gross proceeds ~$2M; net proceeds for working capital and general corporate purposes.
H.C. Wainwright acted as exclusive placement agent; fees include 7.5% cash fee and 68,807 warrant shares.
Closing occurred June 6, 2024; warrants exercisable immediately for 5 years.
Officers and directors subject to 15-day lock-up; company restricted from variable-rate transactions for one year.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.